Detailansicht

Wissensnetz

Person

Johannes Waltenberger

Arzt

Name	Johannes Waltenberger
Ort	Heidelberg (Wirkungsort) Deutschland
Akademischer Grad bzw. Titel	Dr. med. (an der Medizinischen Fakultät der Universität Heidelberg)
Beruf	Arzt (charakteristischer Beruf)
Datensatztyp	Person
GND-Nummer	1140667041
Datensatz-ID	1140667041
Beteiligt an alle anzeigen The Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitor Empagliflozin Reverses Hyperglycemia-Induced Monocyte and Endothelial Dysfunction Primarily through Glucose Transport-Independent but Redox-Dependent Mechanisms Functional evaluation of the PTPase DEP-1 as a novel regulator of monocytes and macrophages in diabetes and inflammation Unmet medical needs in intermittent Claudication with diabetes and coronary artery disease—A “real‐world” analysis on 21 197 PAD patients Association of FKBP5 genotype with depressive symptoms in patients with coronary heart disease: a prospective study Association of FKBP5 genotype with depressive symptoms in patients with coronary heart disease: a prospective study Brain-derived neurotrophic factor, depressive symptoms and somatic comorbidity in patients with coronary heart disease Enhanced External Counterpulsation as a New Treatment Modality for Patients with Erectile Dysfunction Funktion und Regulation von Wachstumsfaktoren in der Gefäßwand : Implikationen für die Therapie kardiovaskulärer Erkrankungen

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Johannes Waltenberger

The Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitor Empagliflozin Reverses Hyperglycemia-Induced Monocyte and Endothelial Dysfunction Primarily through Glucose Transport-Independent but Redox-Dependent Mechanisms

Functional evaluation of the PTPase DEP-1 as a novel regulator of monocytes and macrophages in diabetes and inflammation

Unmet medical needs in intermittent Claudication with diabetes and coronary artery disease—A “real‐world” analysis on 21 197 PAD patients

Association of FKBP5 genotype with depressive symptoms in patients with coronary heart disease: a prospective study

Association of FKBP5 genotype with depressive symptoms in patients with coronary heart disease: a prospective study

Brain-derived neurotrophic factor, depressive symptoms and somatic comorbidity in patients with coronary heart disease

Enhanced External Counterpulsation as a New Treatment Modality for Patients with Erectile Dysfunction

Funktion und Regulation von Wachstumsfaktoren in der Gefäßwand : Implikationen für die Therapie kardiovaskulärer Erkrankungen